Kearsley-Fleet, Lianne ORCID: 0000-0003-0377-1575, Klotsche, Jens, van Straalen, Joeri W., Costello, Wendy, D'Angelo, Gianfranco, Giancane, Gabriella, Horneff, Gerd, Klein, Ariane, Laday, Matilda, Lunt, Mark, de Roock, Sytze, Ruperto, Nicolino, Schoemaker, Casper, Vijatov-Djuric, Gordana, Vojinovic, Jelena, Vougiouka, Olga, Wulffraat, Nico M., Hyrich, Kimme L., Minden, Kirsten and Swart, Joost F. (2022). Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries. RHEUMATOLOGY, 61 (6). S. 2524 - 2535. OXFORD: OXFORD UNIV PRESS. ISSN 1462-0332

Full text not available from this repository.

Abstract

Objectives Burden of comorbidities are largely unknown in JIA. From 2000, national and international patient registries were established to monitor biologic treatment, disease activity and adverse events in patients with JIA. The aim of this analysis was to investigate in parallel, for the first time, three of the largest JIA registries in Europe/internationally-UK JIA Biologic Registers (BCRD/BSPAR-ETN), German biologic registers (BiKeR/JuMBO), multinational Pharmachild-to quantify the occurrence of selected comorbidities in patients with JIA. Methods Information on which data the registers collect were compared. Patient characteristics and levels of comorbidity were presented, focussing on four key conditions: uveitis, MAS, varicella, and history of tuberculosis. Incidence rates of these on MTX/biologic therapy were determined. Results 8066 patients were registered into the three JIA registers with similar history of the four comorbidities across the studies; however, varicella vaccination coverage was higher in Germany (56%) vs UK/Pharmachild (16%/13%). At final follow-up, prevalence of varicella infection was lower in Germany (15%) vs UK/Pharmachild (37%/50%). Prevalence of TB (0.1-1.8%) and uveitis (15-19%) was similar across all registers. The proportion of systemic-JIA patients who ever had MAS was lower in Germany (6%) vs UK (15%) and Pharmachild (17%). Conclusion This analysis is the first and largest to investigate the occurrence of four important comorbidities in three JIA registries in Europe and the role of anti-rheumatic drugs. Combined, these three registries represent one of the biggest collection of cases of JIA worldwide and offer a unique setting for future JIA outcome studies.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Kearsley-Fleet, LianneUNSPECIFIEDorcid.org/0000-0003-0377-1575UNSPECIFIED
Klotsche, JensUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
van Straalen, Joeri W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Costello, WendyUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
D'Angelo, GianfrancoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Giancane, GabriellaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Horneff, GerdUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Klein, ArianeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Laday, MatildaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lunt, MarkUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
de Roock, SytzeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ruperto, NicolinoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schoemaker, CasperUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vijatov-Djuric, GordanaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vojinovic, JelenaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vougiouka, OlgaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wulffraat, Nico M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hyrich, Kimme L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Minden, KirstenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Swart, Joost F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-695828
DOI: 10.1093/rheumatology/keab641
Journal or Publication Title: RHEUMATOLOGY
Volume: 61
Number: 6
Page Range: S. 2524 - 2535
Date: 2022
Publisher: OXFORD UNIV PRESS
Place of Publication: OXFORD
ISSN: 1462-0332
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
MACROPHAGE ACTIVATION SYNDROME; VARICELLA; HEALTH; VACCINATIONMultiple languages
RheumatologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/69582

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item